eXoZymes CEO将出席在纽约市举行的11月3日投资者会议,展示AI设计的可持续化学品生产外音。 eXoZymes CEO will present at Nov. 3 investor conference in NYC, showcasing AI-designed exozymes for sustainable chemical production.

eXoZymes Inc. (NASDAQ:EXOZ)宣布,首席执行官Michael Heltzen将于2025年11月3日出席在纽约市举行的斯巴达资本证券投资者会议。 eXoZymes Inc. (NASDAQ: EXOZ) announced that CEO Michael Heltzen will present at the Spartan Capital Securities Investor Conference on November 3, 2025, in New York City. 本次活动将包括技术、保健和消费部门60多个增长公司以及500+投资者。 The event will feature over 60 growth companies across technology, healthcare, and consumer sectors, along with 500+ investors. Heltzen将在上午11时20分至11时35分在第4轨发言,重点介绍该公司的AI工程外子-酶设计,目的是在生物细胞外工作,将生物物质转化为营养素、药物和化学物质。 Heltzen will speak from 11:20 to 11:35 AM in Track 4, highlighting the company’s AI-engineered exozymes—enzymes designed to work outside living cells to convert biomass into nutraceuticals, medicines, and chemicals. 这些外酶旨在用可持续的,可扩展的替代品取代石化和低效的生物化学过程, These exozymes aim to replace petrochemical and inefficient biochemical processes with sustainable, scalable alternatives, potentially setting a new industry standard. 会议包括演讲、小组讨论和投资者会议。 The conference includes presentations, panels, and investor meetings.